Tagged with “FY 2011”

House Appropriations Subcommittee Approves Increase in Funding for the FDA

Today, the House Appropriations Agriculture Subcommittee met to consider the fiscal year 2011 bill that funds the Food and Drug Administration (FDA). The Subcommittee approved $2.571 billion in funding for the FDA.

This is an increase of $214 million above last year’s level and $55 million above the President’s request. C3 is very pleased with this proposed increase, and applauds the leadership of Chairwoman De Lauro, Ranking Member Kingston and the members of the Subcommittee.

Earlier this month, C3 advocates went to Capitol Hill to urge Congress to increase funding for the FDA. Register today as a C3 advocate, and we will update you on what you can do to help us make sure this increased funding for the FDA stays in the bill as it moves through the appropriations process.

Posted by Catherine Knowles on June 30th, 2010
Posted in: Policy & Advocacy News | No Comments »
Tags: Appropriations, Commissioner Hamburg, Congressman Hinchey, Congressman Kingston, Congresswoman DeLauro, Congresswoman Emerson, FDA, FY 2011, Senator Grassley

C3 President Carlea Bauman Testifies at Congressional Hearing

C3 President Carlea Bauman Today, the House Committee on Appropriations Subcommittee on Defense held a public witness hearing about funding needs for the fiscal year 2011 defense appropriations bill. C3′s President, Carlea Bauman, testified at the hearing about the urgent need for more funding for colorectal cancer research.

Ms. Bauman thanked the Subcommittee members for including $15 million for the Department of Defense (DoD)’s Peer Reviewed Cancer Research Program (PRCRP) in the fiscal year 2010 bill and urged them to increase the level of funding for the PRCRP to $50 million in fiscal year 2011. Continue reading…

Posted by Catherine Knowles on May 20th, 2010
Posted in: C3 News, Policy & Advocacy News, Research & Treatment News | No Comments »
Tags: Appropriations, cancer research, DoD, FY 2011, House of Representatives, Peer Reviewed Cancer Research Program, PRCRP